These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 2596945)

  • 1. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES; Lyles KW; Singer FR; Meunier PJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG; Caldwell JG
    J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V
    Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F; Ringe JD; Kruse HP
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Drake S; Massie JD; Postlethwaite AE; Palmieri GM
    Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
    Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG; Lim EM; Kent GN; Ward LC; Gutteridge DH
    J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pamidronate infusions for the treatment of Paget's disease of bone.
    Mazieres B; Ahmed I; Moulinier L; Bon E; Cantagrel A; Laroche M
    Rev Rhum Engl Ed; 1996 Jan; 63(1):36-43. PubMed ID: 9064108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paget's disease of bone: experience from a centre in southern India.
    Anjali ; Thomas N; Rajaratnam S; Shanthly N; Oommen R; Seshadri MS
    J Assoc Physicians India; 2006 Jul; 54():525-9. PubMed ID: 17089899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
    O'Doherty DP; Gertz BJ; Tindale W; Sciberras DG; Survill TT; Kanis JA
    J Bone Miner Res; 1992 Jan; 7(1):81-7. PubMed ID: 1549961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM; Au-Yeong ML; McKenna MJ
    Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic human calcitonin in refractory Paget's disease of bone.
    Altman RD; Collins-Yudiskas B
    Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.